ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

Breast Cancer Coalition to Congress: ‘Find a Way To Fund The War,’ Bypass Level Is Not Enough

August 7, 1992

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991